Variable virulence factors in Burkholderia pseudomallei (Melioidosis) associated with human disease

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Sarovich, Derek S ^a   Price, Erin P ^a   Webb, Jessica R ^a   Ward, Linda M ^a   Voutsinos, Marcos Y ^a   Tuanyok, Apichai ^b   Mayo, Mark ^a   Kaestli, Mirjam ^a   Currie, Bart J ^a,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF HAWAII   (United States)

^c ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR; ACTIN BINDING PROTEIN; BIMA PROTEIN, BURKHOLDERIA PSEUDOMALLEI;

ACTIN POLYMERIZATION; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL VIRULENCE; BIMABM GENE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL FEATURE; DATA ANALYSIS; DISEASE SEVERITY; ENCEPHALOMYELITIS; FHAB3 GENE; GENE CLUSTER; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; GENOME ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; MELIOIDOSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PNEUMONIA; SKIN DEFECT; AUSTRALIA; GENETICS; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; HUMANS; MELIOIDOSIS; MICROFILAMENT PROTEINS; VIRULENCE; VIRULENCE FACTORS;

EID: 84897532697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091682     Document Type: Article

References (35)

1. Butler D (2012) Viral research faces clampdown. Nature 490: 456.
2. Limmathurotsakul D, Dance DA, Wuthiekanun V, Kaestli M, Mayo M, et al. (2013) Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis 7: e2105.
3. Currie BJ, Ward L, Cheng AC (2010) The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4: e900.
4. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, et al. (2010) Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 82: 1113-1117.
5. Limmathurotsakul D, Chaowagul W, Wongsrikaew P, Narmwong A, Day NP, et al. (2007) Variable presentation of neurological melioidosis in Northeast Thailand. Am J Trop Med Hyg 77: 118-120. (Pubitemid 351844362)
6. Currie BJ, Fisher DA, Howard DM, Burrow JN (2000) Neurological melioidosis. Acta Trop 74: 145-151. (Pubitemid 30069786)
7. Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, Baker PJ, Bokori-Brown M, et al. (2011) A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 334: 821-824.
8. Reckseidler SL, DeShazer D, Sokol PA, Woods DE (2001) Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 69: 34-44. (Pubitemid 32038296)
9. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, et al. (2011) The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun 79: 1512-1525.
10. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ (2006) Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4: 272-282.
11. Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, et al. (2005) Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol Microbiol 56: 40-53. (Pubitemid 40461486)
12. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, et al. (2011) Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A 108: 12095-12100.
13. Sitthidet C, Korbsrisate S, Layton AN, Field TR, Stevens MP, et al. (2011) Identification of motifs of Burkholderia pseudomallei BimA required for intracellular motility, actin binding, and actin polymerization. J Bacteriol 193: 1901-1910.
14. Sitthidet C, Stevens JM, Chantratita N, Currie BJ, Peacock SJ, et al. (2008) Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol 46: 2418-2422.
15. Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, et al. (2001) Glanders in a military research microbiologist. N Engl J Med 345: 256-258. (Pubitemid 32695065)
16. Sitthidet C, Stevens JM, Field TR, Layton AN, Korbsrisate S, et al. (2010) Actin-based motility of Burkholderia thailandensis requires a central acidic domain of BimA that recruits and activates the cellular Arp2/3 complex. J Bacteriol 192: 5249-5252.
17. El Tahir Y, Skurnik M (2001) YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol 291: 209-218. (Pubitemid 32818131)
18. Mukhopadhyay C, Kaestli M, Vandana KE, Sushma K, Mayo M, et al. (2011) Molecular characterization of clinical Burkholderia pseudomallei isolates from India. Am J Trop Med Hyg 85: 121-123.
19. Massey S, Johnston K, Mott TM, Judy BM, Kvitko BH, et al. (2011) In vivo bioluminescence imaging of Burkholderia mallei respiratory infection and treatment in the mouse model. Front Microbiol 2: 174.
20. Owen SJ, Batzloff M, Chehrehasa F, Meedeniya A, Casart Y, et al. (2009) Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 199: 1761-1770.
21. Lopez J, Copps J, Wilhelmsen C, Moore R, Kubay J, et al. (2003) Characterization of experimental equine glanders. Microbes Infect 5: 1125-1131. (Pubitemid 37211474)
22. Chieng S, Carreto L, Nathan S (2012) Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics 13: 328.
23. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, et al. (2008) Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 9: 566.
24. Sim SH, Yu Y, Lin CH, Karuturi RK, Wuthiekanun V, et al. (2008) The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis. PLoS Pathog 4: e1000178.
25. Dowling AJ, Wilkinson PA, Holden MT, Quail MA, Bentley SD, et al. (2010) Genome-wide analysis reveals loci encoding anti-macrophage factors in the human pathogen Burkholderia pseudomallei K96243. PLoS One 5: e15693.
26. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S (2000) Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun 68: 5377-5384.
27. Clantin B, Delattre AS, Rucktooa P, Saint N, Meli AC, et al. (2007) Structure of the membrane protein FhaC: a member of the Omp85-TpsB transporter superfamily. Science 317: 957-961. (Pubitemid 47301325)
28. Poolman JT, Hallander HO (2007) Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 6: 47-56. (Pubitemid 46232480)
29. Gibney KB, Cheng AC, Currie BJ (2008) Cutaneous melioidosis in the tropical Top End of Australia: a prospective study and review of the literature. Clin Infect Dis 47: 603-609.
30. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ (2008) Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 5: e175.
31. Tuanyok A, Auerbach RK, Brettin TS, Bruce DC, Munk AC, et al. (2007) A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol 189: 9044-9049.
32. Fierer J, Guiney DG (2001) Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest 107: 775-780. (Pubitemid 32274025)
33. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, et al. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503. (Pubitemid 29091254)
34. Holden MT, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Atkins T, et al. (2004) Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 101: 14240-14245. (Pubitemid 39305059)
35. Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, et al. (2012) Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol 50: 2059-2062.